Gloshell
Ingredients

Ingredient Dictionary

SACCHAROMYCES CEREVISIAE EXTRACT

Photo

How much products actually contain

12 products state the amountmedian 81%

  • under 0.01% 1
  • 0.01–0.1% 1
  • 0.1–1% 0
  • 1% or more 10

Amounts are mostly stated by products named after the ingredient, so they may lean towards token amounts.

Of the products containing it, 42 list it before the 1% line and 53 after it (usually 1% or less).

Products using this ingredient

12 of 91 confirmed · likeliest to carry enough first · See all 91

Definition

Saccharomyces Cerevisiae Ferment is an extract of the yeast cells of Saccharomyces Cerevisiae

Biological origin: Saccharomyces cerevisiae (Desm.) Meyen · family Saccharomycetaceae · fungus

Source: GBIF species information

Cosmetic roles

Keeps skin in good condition (CosIng catch-all)SKIN CONDITIONING

Safety & regulatory references

Reviewed by CIR: Final Report: Safety Assessment of Yeast-Derived Ingredients as Used in Cosmetics

Source: US Cosmetic Ingredient Review (CIR)

More data — names, identifiers, properties, test records, literature

Official labels & definitions

JCIA labelling name サッカロミセスセレビシアエエキス: 本品は、酵母 Saccharomyces cerevisiae から得られるエキスである。

Source: JCIA labelling names (Japan)

Names & identifiers

SACCHAROMYCES CEREVISIAE EXTRACTINCI맥주효모추출물Korean label name (MFDS standard)サッカロミセスセレビシアエエキスJapanese labelling name
CAS No.chemical registry number
84604-16-0
EC No.EU chemical inventory number
283-294-5
DTXSIDUS EPA chemical ID
DTXSID001042457

Irritation and sensitisation studies

3 skin studies and 1 eye studies are on record.

Classed as highly irritating1Classed as low4

The studies disagree (the most common conclusion covers 20%), so they do not establish that this ingredient is irritating. These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 4 studies
  • High Frequency of Sensitization
    skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay) according to EPA OPPTS 870.2600 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay) according to EPA OPPTS 870.2600 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF), 12 Nousan, Notification No 8147, November 2000, including the most recent partial revisions. according to OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to EPA OPPTS 870.2400 (Acute Eye Irritation) according to

Source: US EPA CompTox dashboard

Related literature

Linked databases 9